Pharmafile Logo
Pharmafocus logo
Advanced Search

Intervention from Paris secures French future for Aventis

May 7, 2004

Aventis has dropped its long-running opposition to a takeover bid by French compatriots Sanofi-Synthlabo after the offer to its shareholders …

News

OTC Zocor to be cleared but divisions persist

April 28, 2004

The government is shortly to announce the approval of the world's first over-the-counter statin, Zocor Heart Pro, but is unlikely …

News

Burson-Marsteller to launch cancer treatment in the UK

April 28, 2004

Burson-Marsteller, a subsidiary of the WPP advertising giant, has been appointed PR campaign handler for the UK launch of Velcade, …

News

NHS finances a cause for concern, says watchdog

April 28, 2004

News

Patients still being denied access to colon cancer treatments

April 28, 2004

A new Roche-sponsored survey of patients with bowel cancer has found that most are still not being consulted on the …

News

BMA chairman warns reforms add to threat of ‘two-tier NHS’

April 26, 2004

The chairman of the BMA has warned that new reforms are adding to the threat of a two-tier NHS posed …

News

US legal action Aventis’ latest weapon in repelling Sanofi

April 26, 2004

Aventis has unleashed its latest stratagem in resisting Sanofi-Synthleabo's hostile takeover bid, a US legal action claiming its rival has …

News

A tale of two pills for Pfizer in Q1

April 26, 2004
Pfizer, torceptrapib

 The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …

News

Aventis’ Apidra approved in US

April 26, 2004

The FDA has approved Aventis' rapid-acting insulin analogue Apidra, ahead of an anticipated August approval by the EMEA, as the …

News

No change one year on from NSF, says diabetes charity

April 26, 2004

One year on from the launch of the National Service Framework (NSF) for Diabetes, the planning of care has improved …

News

Wyeth’s Zoton hot on the heels of over-the-counter Zanprol

April 26, 2004

Wyeth, manufacturers of the UK's biggest selling prescription drug Zoton plan to take the drug POM-P, hot on the heels …

News

The brave new GMS world

April 26, 2004

The new General Medical Services contract (nGMS) started officially on 1st April, though its far-reaching effects may be far from …

Feature

Supporting the everyday experts

April 26, 2004

We are all familiar with the growth of the ageing population during the second half of the 20th century and …

Feature

Targeting the new prescribers

April 26, 2004

Feature

Sanofi slims down portfolio in preparation for Aventis acquisition

April 15, 2004

Sanofi-Synthelabo has agreed to sell two of its products to GlaxoSmithKline, as it seeks to avoid potential problems with competition …

News

Britannia and Otsuka collaborate on autoimmune disease treatment

April 15, 2004

Britannia Pharmaceuticals has entered into an agreement with Otsuka Pharmaceuticals UK to manage the UK distribution of the novel treatment …

News

Heart concerns halt Acambis trials

April 15, 2004

UK biotech Acambis has suspended Phase III clinical trials of its smallpox vaccine after three patients suffered a heart inflammation …

News

Humira gives Abbott a shot in the arm

April 15, 2004

News

Avastin gets off to a flying start

April 15, 2004

US biotech Genentech's first quarter results have surpassed estimates as the company posted profit growth of 17% to $176.6 million, …

News

Merck and S-P’s cholesterol combination approved in Germany

April 15, 2004

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026